Pfizer’s Covid-19 vaccine reduces the risk of omicron infection by 31% among children age 5-11 and by 59% among children age 12-15, according to a study by the Centers for Disease Control and Prevention.
Pfizer’s Covid-19 vaccine reduces the risk of omicron infection by 31% among children age 5-11 and by 59% among children age 12-15, according to a study by the Centers for Disease Control and Prevention.